« Back to Record
Ignatiadis, M., Zardavas, D., Lemort, M., Wilke, C., Vanderbeeken, M., D'Hondt, V., de Azambuja, E., Gombos, A., Lebrun, F., Dal Lago, L., Bustin, F., Maetens, M. M., Ameye, L., Veys, I., Michiels, S., Paesmans, M., Larsimont, D., Sotiriou, C., Nogaret, J.-M., Piccart-Gebhart, M., & Awada, A. (2016). Feasibility study of EndoTAG-1, a tumor endothelial targeting agent, in combination with paclitaxel followed by FEC as induction therapy in HER2-negative breast cancer. PloS one, 11(7), e0154009. doi:10.1371/journal.pone.0154009
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/237798



